KRIBIOLISA™ Pasotuxizumab ELISA

SKU: KBI1546 Category:

₹85,000.00

Enzyme Immunoassay for the estimation of Pasotuxizumab in serum and plasma.

About the kit:
– Uses anti-idiotypic monoclonal antibodies which ensures higher specificity, and low cross reactivity.
– Recovery rates are between 85 – 115%
– Validated as per US FDA guidelines for Bioassays
– Precision CV<10%

Availability: 3 – 4 Weeks | Pack Size: 1 x 96 wells

Description

Background:
Pasotuxizumab is a canonical PSMA x CD3 BiTE molecule with potent in vitro and in vivo cytotoxicity activity. It is under investigation as an immune therapy mediating T-cell killer of tumor cells in patients with advanced castration-resistant prostate cancer.

Intended Use:
For Estimation of Pasotuxizumab in human serum and plasma. Please note the kit has not been optimized to be used for any other animal species. Should you require a specific sera tested, please connect with us at sales@krishgen.com for optimization.

If you have published a paper by using any of our ELISA since 01/01/2023, kindly fill out the “Krishgen Publication Reward Application Form” with complete information and send it by at email: info@krishgen.com, with the subject “Krishgen Publication Reward”. We will get back to you with the Amazon / Krishgen Credit Reward after we confirm it ASAP!

View more details about our Publication Reward

Additional information

Calibration Range

0 ng/ml – 2000 ng/ml
Detection Method

Colorimetric @ 450nm
Specificity

80% – 120% to Pasotuxizumab
Cross Reactivity

< 0.5% cross-reactivity observed with related biomarker.
Interference

No significant interference observed with available related molecules.
Regulatory Status

Research Use Only
Storage Temprature

Store the unopened product at 2-8 Degree Celcius. Concentrated detection conjugate should be stored at -20 Degree Celcius. Do not use past expiration date.
Shipping Temperature

2-8 Degree Celcius. Concentrated detection conjugate ship at -20 Degree Celcius in a second box. Freight applicable for both.
Research Area

Biosimilars / Therapeutic Drug Monitoring
ELISA Type

Direct Sandwich Assay
Validation

The kit uses a biosimilar research grade standard / calibrator. The standard / calibrator has been validated against WHO/NIBSC standard and/or against commercially sourced innovator drug where available. Please refer the IFU for more details.
Disclaimer

Trade name indicated is for reference purposes only. It does not reflect any licences or patent usage. The tradename is the registered trademark of the respective owners only.
Long Name

Protein Based Therapies – Monoclonal Antibody

Related products